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INTRODUCTION
Bipolar patients often experience subtle cognitive impair-
ment (1-4) and functional disturbances during their euthymic
states (5, 6). These subjective experiences may be related to
distorted cognitive functions in these patients (7). The sub-
jective experience of cognitive impairment may result from
problems in central executive functions (8) or may be relat-
ed to attentional style associated with stress (9). Such cogni-
tive impairments consequently imply a breakdown in super-
vising attention systems. Because cognitive ability is critical
in interpersonal relationships and social skills, the persistence
of functional disturbances among euthymic bipolar patients
may therefore be explained by cognitive impairment.
Most studies of subjective experiences have been conducted
in patients with schizophrenia (10, 11). It is generally accept-
ed that cognitive dyfunction persists in the remitted schizo-
phrenics (2, 7, 12). In contrast, we do not have definite evi-
dence of persistent cognitive dyfunction in euthymic patients
with bipolar disorder (13-15). More recently, however, the
number of studies on the persistence of cognitive and per-
ceptual distortion in bipolar patients has increased (15-17).
To date, little attention has been paid to subjective cogni-
tive impairment in bipolar disorder. To our knowledge, there
are few studies to compare subjective experience of patients
with bipolar disorder with the patients with schizophrenia, and
the results were inconsistent (3, 4, 12).
Subjective experiences are evaluated with questionnaires,
which have shown only a moderate correlation with objective
performance. Since subjective experiences may be distinct
from objective pathology (18, 19), it is necessary to evaluate
subjective experiences and objective symptoms separately.
Representative tools available to evaluate subjective experi-
ences are the Frankfurter Beschwerde Fragebogen (FBF) (20),
the Bonn Scale of the Assessment of Basic Disturbances in
Schizophrenia (BSABS) (11) and the Symptom Check List
90-R (SCL90-R) (21, 22). The FBF is used primarily to eval-
uate cognitive disturbances (20, 23), whereas the SCL90-R
is used to evaluate a broader range of subjective psychiatric
complaints (21).
The aims of this study were as follows: first, we tried to deter-
mine if euthymic bipolar patients experience subjective symp-
tom that is distinguishable from the normal controls. Sec-
ond, we tried to know if their subjective experiences are com-
parable to those of schizophrenics. Third, we also tried to
determine whether these subjective experiences are affected
primarily by cognitive impairment or by the perception of
discomfort secondary to mood and psychotic symptoms.
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Experience of Subjective Symptoms in Euthymic Patients with Bipolar
Disorder
Bipolar patients often experience subjective symptoms even if they do not have active
psychotic symptoms in their euthymic state. Most studies about subjective symptoms
are conducted in schizophrenia, and there are few studies involving bipolar patients.
We examined the nature of the subjective symptoms of bipolar patients in their euthymic
state, and we also compared it to that of schizophrenia and normal control. Thirty
bipolar patients, 25 patients with schizophrenia, and 21 normal control subjects were
included. Subjective symptoms were assessed using the Korean version of the
Frankfurter Beschwerde Fragebogen (K-FBF) and the Symptom Check List 90-R
(SCL90-R). Euthymic state was confirmed by assessing objective psychopatholo-
gy with the Positive and Negative Syndrome scale of Schizophrenia (PANSS), the
Young Mania Rating Scale (YMRS), and the Montgomery Asberg Depression Rat-
ing Scale (MADRS). K-FBF score was significantly higher in bipolar patients than
in normal controls, but similar to that in schizophrenia patients (F=5.86, p=0.004,
R
2=2033.6). In contrast, SCL90-R scores did not differ significantly among the three
groups. Euthymic bipolar patients experience subjective symptoms that are more
confined to cognitive domain. This finding supports the hypothesis that subtle cog-
nitive impairments persists in euthymic bipolar patients.
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MATERIALS AND METHODS
Subjects
Subjects with bipolar disorder and schizophrenia were re-
cruited at the psychiatric department of a tertiary referral cen-
ter with an inpatient ward for acute psychiatric patients be-
tween May and September 2004. Consecutively admitted
patients who were diagnosed as bipolar I disorder or schizo-
phrenia by Diagnostic and Statistical Manual for psychiatric
disorder-IV criteria (24) were included. Total 72 subjects met
the inclusion criteria (38 bipolar and 34 schizophrenia).
Of the 72 subjects who met the inclusion criteria, all gave
informed consent. To avoid diagnostic uncertainties related
to the spectrum of schizophrenia, patients who had psychotic
periods without mood symptoms or mood incongruent psy-
chotic symptoms were excluded (2 bipolar patients). We also
excluded patients who failed to complete the questionnaires
(1 schizophrenia and 2 bipolar patients), who had a history
of organic mental disorder (1 bipolar and 3 schizophrenia
patients), or who were currently abusing drugs or alcohol (3
bipolar and 4 schizophrenia patients). Thus, the patient sam-
ple consisted of 30 patients with bipolar disorder and 25 pa-
tients with schizophrenia.
Normal controls were recruited by advertisement. We
interviewed 26 individuals. We investigated their demo-
graphic data, medical and psychiatric history. We excluded
individuals with any medical or psychiatric illness that might
affect cognitive function. We applied the same exclusion cri-
teria as applied to the patient groups, leaving 21 normal con-
trol subjects.
Assessment
For patients with bipolar disorder and schizophrenia, data
on illness characteristics, including the number of episodes,
duration of illness, and family history, were compiled from
patient interviews and medical records. In patients of whom
we could not determine the age of onset, we used the age at
first admission.
One of the authors conducted the clinical assessment.
Objective psychopathology was assessed using the Positive
and Negative Syndrome Scale of Schizophrenia (PANSS) (25-
27), the Young Mania Rating Scale (YMRS) (28), and the
Montgomery Asberg Depression Rating Scale (MADRS)
(29). Euthymia was defined as a YMRS total score ≤12 (30)
and a MADRS cutoff value ≤9 (31). Every bipolar patient
was in an euthymic state. The PANSS total score of every
schizophrenia patient was less than 60, and the mean of any
three subscales of the PANSS (i.e. the PANSS positive, neg-
ative, and general scales) was not greater than 3 (mild).
Subjective cognitive impairments were assessed using the
Korean version of the Frankfuter Beschwerde Frageboden (K-
FBF) (32) and the SCL90-R (22). The K-FBF and SCL90-R
are self-reporting scales. The K-FBF consists of 103 items and
10 phenomenological areas. Ten phenomenological areas are
specific anxiety, selective attention, deterioration of discrim-
ination, psychomotor disorder, perceptual disorder, cognitive
floating, blocking symptoms, language disorder, automatic
behavior disorder, and coping responses. Each item consists of
a 6-point response scale, from ‘strongly disagree’ (1) to ‘strong-
ly agree’ (5). As mentioned before, an abnormality assessed
by the K-FBF is known to reflect cognitive dysfunction. We
obtained total scores of K-FBF, which is standardized by sex
and age in each of the three groups. The SCL90-R consists of
9 dimensions and 90 items. Nine dimensions are ‘somatiza-
tion’, ‘obsessive-compulsive’, ‘interpersonal sensitivity’, ‘depres-
sion’, ‘anxiety’, ‘depression’, ‘hostility’, ‘phobic anxiety’, ‘para-
noid ideation’, and ‘psychoticism’. Each item consists of 5-
point response scale, from ‘not at all’ to ‘very severe’. Since
it contains comprehensive psychiatric symptoms, it is useful
for assessing overall subjective dysfunction. Standardized total
score of SCL90-R that is called the ‘global score index’ was
obtained in each of the three groups.
Statistical analysis
Analysis of variance (ANOVA) and the Kruskal-Wallis test
were used to examine the differences among the three groups,
and post hoc analysis was performed by the Duncan method.
Independent t-test, Mann-Whitney U test, and Fisher’s exact
test were used to examine the difference between schizophre-
nia and bipolar disorder groups. All statistical analyses were
performed using SPSS version 11.0 for Windows.
RESULTS
Demographic data and clinical characteristics
Table 1 shows the demographic characteristics of the bipolar
disorder, schizophrenia, and normal control groups. There
were no significant differences in the distribution of sex ( 2=
0.819, df=2, p=0.664), age (F=0.189, df=2, p=0.828), and
education years (F=2.953, df=2, p=0.058) among the three
groups. There were significant differences in the employment
( 2=25.02, df=2, p<0.001), distribution of socioeconomic
status ( 2=11.66, df=4, p<0.020), and marital status ( 2=
60.32, df=6, p<0.001) among the three groups. There was
no significant differences in employment ( 2=0.262, df=1,
p=0.609), socioeconomic status ( 2=7.087, df=2, p=0.069)
and marital status ( 2=0.794, df=3, p=0.672) between the
bipolar disorder group and schizophrenia group. However,
the bipolar disorder group showed a significantly lower rate
of employment ( 2=23.03, df=1, p<0.001) than the normal
control group. There were also significant differences in mar-
ital status ( 2=34.33, df=3, p<0.001) and socioeconomic
status ( 2=10.99, df=2, p=0.004) between the bipolar dis-20 S. Joe, Y. Joo, S. Kim
order group and the schizophrenia group.
There was no significant difference in the number of previous
episode (t=-0.622, df=53, p=0.537), age at onset (t=-1.101,
df=53, p=0.276), duration of illness (t=-1.831, df=53, p=
0.073), hospitalized period (t=-0.915, df=2, p=0.640), YMRS
(t=-1.473, df=53, 0.147), and PANSS positive symptom score
(t=1.556, df=2, p=0.126) between the bipolar disorder group
and the normal control group.
The bipolar disorder group showed significantly lower
MADRS (t=2.557, df=2, p=0.013) and PANSS total (t=
6.494, df=53, p<0.001), negative symptom (t-5.254, df=2,
p<0.001), and general symptom score (t=5.301, df=2, p<
0.001) than the schizophrenia group (Table 2). There were
no other significant differences between the bipolar disorder
and schizophrenia groups.
Subjective experiences in the three groups
The K-FBF score differed significantly among the three
groups (Table 3) by ANOVA. The K-FBF standardized total
score was significantly higher among bipolar patients than
among normal controls, but was similar to the score of schi-
zophrenia patients (F=5.86, p=0.004, R2=2033.6). In con-
trast, the standardized total score on the SCL90-R did not
differ significantly among the three groups (F=3.102, p=
0.051, R2=246.776).
All the phenomenological domain of K-FBF showed sig-
nificant difference among the three groups (Table 4). The
scores were significantly higher in the bipolar group than in
the normal control group, and they were similar between the
bipolar group and schizophrenia group.
Most dimension scores of SCL90-R did not show a signif-
icant difference among the three groups except depression,
anxiety, phobic anxiety, and paranoid ideation (Table 5). Depres-
sion, anxiety, phobic anxiety, and paranoid ideation subscale
scores of the bipolar group were similar to those of the normal










Female (%) 12 (40.0) 13 (52.0) 10 (47.6) 0.819 0.664
Male (%) 18 (60.0) 12 (48.0) 11 (52.4)
Age, yr (mean±SD) 35.0±11.0 34.0±8.7 33.57±4.1 0.189 0.828
Employed (%) 10 (33.3) 10 (40.0) 21 (100) 25.02 <0.001
Education, yr (mean±SD) 12.7±3.3 13.0±3.1 14.62±1.8 2.953 0.058
Marital status 60.32 <0.001
Single (%) 12 (40.0) 18 (72.0) 0 (0)
Married (%) 11 (36.7) 6 (24.0) 21 (100)
Divorced (%) 5 (16.7) 0 (0) 0 (0)
Separated (%) 0 (0) 0 (0) 0 (0)
Other (%) 2 (6.7) 1 (4.0) 0 (0)
Socioeconomic status 12.27 0.009
Upper (%) 8 (26.7) 4 (16.0) 0 (0)
Middle (%) 18 (60) 17 (68.0) 20 (100)
Lower (%) 4 (13.3) 4 (16.0) 0 (0)







Number of previous episodes 3.16±2.41 3.63±3.10 -0.622 53 0.537
Age at onset, yr (mean±SD) 25.8±9.2 23.4±6.8 -1.101 53 0.276
Duration of illness, months (mean±SD) 93.5±110.8 46.2±72.0 -1.831 53 0.073
Hospitalized period, months (mean±SD) 3.8±3.4 5.8±11.4 0.915 53 0.64
YMRS 5.3±4.6 3.6±4.1 -1.473 53 0.147
MADRS 1.9±2.4 4.1±3.9 2.557 53 0.013
PANSS positive symptoms 8.8±2.0 10.0±3.3 1.556 53 0.126
PANSS negative symptoms 8.4±2.1 13.2±4.5 5.254 53 <0.001
PANSS general symptoms 17.5±2.1 22.4±4.5 5.301 53 <0.001
PANSS total score 34.7±4.6 45.4±7.5 6.494 53 <0.001
Table 2. Clinical characteristics of the bipolar and schizophrenic groups
YMRS, Young Mania Rating scale score; MADRS, Montgomery Asberg Depression Rating Scale score; PANSS, Positive And Negative Syndrome Scale.Subjective Symptoms in Euthymic Bipolar Patients 21
Correlation of subjective experiences and objective psy-
chopathology
There were no significant correlations between K-FBF total
score and PANSS total score (r=0.184, p=0.331), YMRS
total score (r=0.328, p=0.077), and MADRS total score (r=
0.246, p=0.191). Standardized total score (global score index)
of the SCL90-R also showed no significant positive correla-
tions with PANSS total score (r=0.333, p=0.072) and YMRS
total score (r=0.341, p=0.066). The SCL90-R, however, was
significantly correlated with MADRS total scores (r=0.512,
p=0.004).
DISCUSSION
We have shown here that subjective symptoms measured
by K-FBF still exist in the euthymic bipolar patients. It im-
plies the possibility that pathological processes of bipolar
disorder progress silently even in the euthymic state. Cur-
rent routine psychiatric assessments, however, are focused
on objective psychopathology. We recommend to includ
items to evaluate subjective experiences as psychopathologi-
cal assessment tools for bipolar patients. 
In this study, mood states of all subjects were euthymic
and objective psychopathology was not correlated to subjec-
tive symptoms measured by the K-FBF. Thus, subjective
symptoms measured by K-FBF might not be secondary to
psychosis or mood symptoms. This finding further supports
that the subjective experience of bipolar patients is a distinct
pathology from objective pathology.
It is likely that the subjective experiences in bipolar patients
are mainly caused by cognitive impairment. In contrast to
the K-FBF score, which differed significantly between bipo-
lar patients and controls, SCL90-R did not show a significant
difference. The K-FBF mainly measures cognitive impairment
in information processing (20), whereas the SCL90-R also mea-
sures various other physiological symptoms and complaints
than the cognitive domain (21). Thus, the SCL90-R evaluates
overall subjective dysfunction without specific restriction to
the cognitive domain. 
The degree of subjective cognitive impairments, as meas-
ured by the K-FBF, was comparable in bipolar patients and
schizophrenics. Similar to schizophrenics, bipolar patients may
be cognitively impaired. At present, however, we can not say






Specific 3.20±2.28 3.60±2.74 1.90±1.09 3.637 0.031
anxiety
Selective 3.27±2.23 3.84±2.90 1.67±0.92 5.758 0.005
attention
Deterioration 3.40±1.96 4.04±2.76 2.00±0.89 5.771 0.005
of discrimination
Psychomotor 3.67±1.99 3.56±2.52 2.14±0.79 4.342 0.017
disorder
Perceptual 3.13±2.24 3.28±2.62 1.71±0.15 3.667 0.030
disorder
Cognitive 2.97±1.88 4.15±2.93 2.05±0.12 5.682 0.006
floating
Blocking 3.03±1.83 3.68±2.63 1.86±0.15 4.869 0.010
symptoms
Language 3.10±1.90 3.68±2.66 2.10±0.38 3.398 0.039
disorder
Automatic 3.07±1.86 3.96±3.08 1.52±0.75 7.4O7 0.001
behavior disorder
Coping 3.43±2.25 4.04±2.75 4.04±2.75 6.605 0.002
responses
Table 4. Comparison of ten phenomenological subscale of K-
FBF among the three groups
K-FBF, Korean version of Frankfurter Beschwerde Fragebogen; SCL90-








K-FBF 32.27±17.69 37.04±24.81 18.71±8.63 0.004
SCL90-R 41.63±8.96 46.32±11.71 40.19±3.09 0.051
Table 3. Subjective experiences among the three groups
Bipolar disorder  Schizophrenia Normal F p
Somatization 41.03±5.25 44.84±11.74 42.95±4.33 1.613 0.206
Obsessive-compulsive 41.87±11.00 46.28±13.00 40.67±3.41 1.974 0.146
Interpersonal sensitivity 43.00±10.41 47.44±11.40 41.95±4.86 2.232 0.115
Depression 42.47±9.23 47.85±10.63 42.38±4.02 3.254 0.044
Anxiety 42.90±8.15 47.32±11.54 40.62±2.82 3.774 0.028
Hostility 43.37±5.44 45.20±8.68 43.62±4.19 0.617 0.542
Phobic anxiety 45.13±7.21 51.24±14.37 42.29±2.03 0.006
Paranoid ideation 43.67±7.32 50.921±2.94 41.95±4.71 0.002
Psychoticism 44.07±8.58 48.12±9.42 42.81±3.47 0.056
Table 5. Comparison of subscale scores of SCL90-R among the three groups
SCL90-R, Symptom Check List 90-R.
Subscale scores are presented as mean±SD.22 S. Joe, Y. Joo, S. Kim
a common etiology or phenomenological overlapping between
two diseases.
We did not measure the influence of subjective experiences
of bipolar patients on daily interpersonal and social activities
in this study. However, we can be fairly certain that subjec-
tive experiences in euthymic bipolar patients is not routinely
assessed and treated. Subjective experience is clinically neglect-
ed. Further research about their influence on the social and
occupational functions is necessary. Attainment of a euthymic
state may not be sufficient; rather, the remission of subjec-
tive experiences should be the target of treatment.
The present study has several limitations. First, the num-
ber of subjects was small and our patient groups may not be
representative of the overall population of patients with bipo-
lar disorder and schizophrenia. Second, medications that might
have affected the patient’s cognitive ability were not controlled.
Third, we measured only subjective cognitive impairment,
not the level of cognitive impairment objectively. Further
studies including the assessment of objective cognitive impair-
ment will be needed. Fourth, this study did not provide prac-
tical implications of subjective symptoms. Thus, additional
research is necessary to confirm the relationship between sub-
jective symptoms and difficulties in daily lives of individuals
with bipolar disorder.
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